688265 南模生物
已收盘 08-12 15:00:01
资讯
新帖
简况
股市必读：南模生物新发布《2026年半年度业绩预告的自愿性披露公告》
证券之星 · 08-12 01:19
股市必读：南模生物新发布《2026年半年度业绩预告的自愿性披露公告》
破发股南模生物净利预降 2021上市即巅峰国泰海通保荐
中金财经 · 08-11 11:17
破发股南模生物净利预降 2021上市即巅峰国泰海通保荐
股市必读：南模生物（688265）预计2026年1-6月营业收入2.16亿元至2.5亿元
证券之星 · 08-11 01:18
股市必读：南模生物（688265）预计2026年1-6月营业收入2.16亿元至2.5亿元
南模生物（688265）披露2026年半年度业绩预告，8月10日股价上涨8.51%
证券之星 · 08-10 22:21
南模生物（688265）披露2026年半年度业绩预告，8月10日股价上涨8.51%
南模生物(688265.SH)发预减，预计半年度归母净利润800万元至1000万元，同比下降44.96%至55.97%
智通财经 · 08-10 20:45
南模生物(688265.SH)发预减，预计半年度归母净利润800万元至1000万元，同比下降44.96%至55.97%
每周股票复盘：南模生物（688265）因股价涨幅达15%登龙虎榜
证券之星 · 08-09
每周股票复盘：南模生物（688265）因股价涨幅达15%登龙虎榜
8月7日南模生物（688265）龙虎榜数据
证券之星 · 08-07
8月7日南模生物（688265）龙虎榜数据
南模生物新注册《南模生物·笼位系统信息化管理平台V1.0》项目的软件著作权
证券之星 · 07-24
南模生物新注册《南模生物·笼位系统信息化管理平台V1.0》项目的软件著作权
每周股票复盘：南模生物（688265）董事减持600股，占总股本0.0008%
证券之星 · 07-19
每周股票复盘：南模生物（688265）董事减持600股，占总股本0.0008%
南模生物：7月15日董事王津津减持股份合计600股
证券之星 · 07-16
南模生物：7月15日董事王津津减持股份合计600股
股市必读：南模生物（688265）新发布《关于2025年年度报告的信息披露监管问询函的回复公告》
证券之星 · 07-13
股市必读：南模生物（688265）新发布《关于2025年年度报告的信息披露监管问询函的回复公告》
每周股票复盘：南模生物（688265）每股派现0.125元（含税）
证券之星 · 07-12
每周股票复盘：南模生物（688265）每股派现0.125元（含税）
南模生物（688265）披露关于2025年年度报告的信息披露监管问询函的回复公告，7月9日股价上涨1.69%
证券之星 · 07-09
南模生物（688265）披露关于2025年年度报告的信息披露监管问询函的回复公告，7月9日股价上涨1.69%
南模生物（688265）披露关于变更公司财务总监、聘任副总经理的公告，7月6日股价上涨4.36%
证券之星 · 07-06
南模生物（688265）披露关于变更公司财务总监、聘任副总经理的公告，7月6日股价上涨4.36%
每周股票复盘：南模生物（688265）董事拟减持不超0.0032%股份
证券之星 · 06-07
每周股票复盘：南模生物（688265）董事拟减持不超0.0032%股份
破发股南模生物某技术拟减持 2021上市即巅峰募16.5亿
中金财经 · 06-03
破发股南模生物某技术拟减持 2021上市即巅峰募16.5亿
南模生物（688265）披露董事减持股份计划公告，6月2日股价下跌2.39%
证券之星 · 06-02
南模生物（688265）披露董事减持股份计划公告，6月2日股价下跌2.39%
每周股票复盘：南模生物（688265）完成32.672万股限制性股票归属
证券之星 · 05-31
每周股票复盘：南模生物（688265）完成32.672万股限制性股票归属
南模生物（688265）披露2025年限制性股票激励计划首次授予部分第一个归属期第一批归属结果公告，5月26日股价下跌2.49%
证券之星 · 05-26
南模生物（688265）披露2025年限制性股票激励计划首次授予部分第一个归属期第一批归属结果公告，5月26日股价下跌2.49%
每周股票复盘：南模生物（688265）2025年年度股东会多项议案获通过
证券之星 · 05-24
每周股票复盘：南模生物（688265）2025年年度股东会多项议案获通过
加载更多
公司概况
公司名称：
上海南方模式生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-12-28
主营业务：
上海南方模式生物科技股份有限公司的主营业务是基因修饰动物模型的研发、生产、销售和技术服务业务。公司的主要产品是定制化模型、标准化模型、模型繁育、药物评价及表型分析、饲养服务。
发行价格：
84.62
{"stockData":{"symbol":"688265","market":"SH","secType":"STK","nameCN":"南模生物","latestPrice":43.68,"timestamp":1786518001000,"preClose":46.19,"halted":0,"volume":4185043,"delay":0,"changeRate":-0.0543,"floatShares":77963500,"shares":77963500,"eps":0.4244,"marketStatus":"已收盘","change":-2.51,"latestTime":"08-12 15:00:01","open":46.17,"high":46.96,"low":43.3,"amount":188000000,"amplitude":0.0792,"askPrice":43.68,"askSize":94,"bidPrice":43.67,"bidSize":18,"shortable":0,"etf":0,"ttmEps":0.4244,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786584600000},"marketStatusCode":5,"adr":0,"adjPreClose":46.19,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786498200000,1786505400000],[1786510800000,1786518000000]],"highLimit":50.81,"lowLimit":41.57,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":77963513,"isCdr":false,"pbRate":1.99,"roa":"--","peRate":102.921772,"roe":"0.04%","epsLYR":0.42,"committee":-0.147826,"marketValue":3405000000,"turnoverRate":0.0537,"status":1,"afterMarket":{"amount":122304,"volume":2800,"close":43.68,"buyVolume":2100,"sellVolume":0,"time":1786520037746,"indexStatus":"已收盘 08-12 15:30:00","preClose":46.19},"floatMarketCap":3405000000},"requestUrl":"/m/hq/s/688265","defaultTab":"news","newsList":[{"id":"2658912168","title":"股市必读：南模生物新发布《2026年半年度业绩预告的自愿性披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658912168?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:19","pubTimestamp":1786468750,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年半年度业绩预告的自愿性披露公告上海南方模式生物科技股份有限公司预计2026年上半年实现营业收入21,600万元至25,000万元，同比增长10.34%至27.71%；归属于母公司所有者的净利润为800万元至1,000万元，同比下降55.97%至44.96%；若扣除股份支付影响，扣非后净利润为1,300.00万元至1,580.00万元，同比增长47.27%至78.99%。本次业绩预告未经注册会计师审计。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001608.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969805","title":"破发股南模生物净利预降 2021上市即巅峰国泰海通保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969805","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969805?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:17","pubTimestamp":1786418222,"startTime":"0","endTime":"0","summary":"中国经济网北京8月11日讯 南模生物 昨日晚间发布2026年半年度业绩预告的自愿性披露公告。 南模生物上市首日盘中最高价报82.00元，为该股上市以来最高价。 南模生物首次公开发行股票发行费用总额为1.81亿元，其中，保荐及承销费用1.58亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260811/32331205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0201","BK0012","BK0188","IPOS","BK0183","601211","BK1147","BK1564","BK0028","688265","BK0276","BK0184","02611","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658953885","title":"股市必读：南模生物（688265）预计2026年1-6月营业收入2.16亿元至2.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658953885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658953885?lang=zh_cn&edition=full","pubTime":"2026-08-11 01:18","pubTimestamp":1786382307,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，南模生物报收于46.55元，上涨8.51%，换手率9.13%，成交量7.12万手，成交额3.39亿元。交易信息汇总资金流向8月10日主力资金净流入695.35万元，占总成交额2.05%；游资资金净流入1246.98万元，占总成交额3.68%；散户资金净流出1942.33万元，占总成交额5.73%。业绩披露要点业绩预告南模生物预计2026年1–6月归属净利润盈利800万元至1000万元；营业收入2.16亿元至2.5亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658185932","title":"南模生物（688265）披露2026年半年度业绩预告，8月10日股价上涨8.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658185932","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658185932?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:21","pubTimestamp":1786371713,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，南模生物报收于46.55元，较前一交易日上涨8.51%，最新总市值为36.29亿元。该股当日开盘45.0元，最高50.68元，最低43.9元，成交额达3.39亿元，换手率为9.13%。近日，南模生物发布《2026年半年度业绩预告的自愿性披露公告》。公告显示，公司预计2026年上半年实现营业收入21,600万元至25,000万元，同比增长10.34%至27.71%；归属于母公司所有者的净利润为800万元至1,000万元，同比下降55.97%至44.96%。本次业绩预告未经注册会计师审计。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939600","title":"南模生物(688265.SH)发预减，预计半年度归母净利润800万元至1000万元，同比下降44.96%至55.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939600","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658939600?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:45","pubTimestamp":1786365933,"startTime":"0","endTime":"0","summary":"智通财经APP讯，南模生物 发布2026年半年度业绩预告，公司预计2026年半年度实现归属于母公司所有者的净利润为800万元至1000万元，同比下降44.96%至55.97%。预计2026年半年度扣除股份支付影响后实现归属于母公司所有者的净利润为1300万元至1580万元，同比增长47.27%至78.99%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"南模生物(688265.SH)发预减，预计半年度归母净利润800万元至1000万元，同比下降44.96%至55.97%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673907","title":"每周股票复盘：南模生物（688265）因股价涨幅达15%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673907?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:32","pubTimestamp":1786210331,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，南模生物报收于42.9元，较上周的32.66元上涨31.35%。8月3日盘中最低价报32.26元。本周共计1次涨停收盘，无跌停收盘情况。南模生物当前最新总市值33.45亿元，在医疗服务板块市值排名45/51，在两市A股市值排名4033/5205。本周关注点来自交易信息汇总：南模生物因日收盘价格涨幅达到15%登上龙虎榜。此次是近5个交易日内第1次上榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614832","title":"8月7日南模生物（688265）龙虎榜数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657614832?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:45","pubTimestamp":1786095951,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月7日公布的交易公开信息显示，南模生物因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年8月7日收盘，南模生物报收于42.9元，上涨20.0%，涨停，换手率4.96%，成交量3.87万手，成交额1.58亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700030627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653720585","title":"南模生物新注册《南模生物·笼位系统信息化管理平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2653720585","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653720585?lang=zh_cn&edition=full","pubTime":"2026-07-24 02:23","pubTimestamp":1784830993,"startTime":"0","endTime":"0","summary":"证券之星消息，近日南模生物（688265）新注册了《南模生物·笼位系统信息化管理平台V1.0》项目的软件著作权。今年以来南模生物新注册软件著作权1个。结合公司2025年年报财务数据，2025年公司在研发方面投入了8668.85万元，同比增15.61%。通过天眼查大数据分析，上海南方模式生物科技股份有限公司共对外投资了11家企业，参与招投标项目198次；财产线索方面有商标信息95条，专利信息58条，著作权信息12条；此外企业还拥有行政许可56个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400001618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230475","title":"每周股票复盘：南模生物（688265）董事减持600股，占总股本0.0008%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230475","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230475?lang=zh_cn&edition=full","pubTime":"2026-07-19 03:00","pubTimestamp":1784401238,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，南模生物报收于33.99元，较上周的36.3元下跌6.36%。7月14日盘中最低价报32.9元。南模生物当前最新总市值26.5亿元，在医疗服务板块市值排名47/51，在两市A股市值排名4382/5199。本周关注点股本股东变化：董事王津津减持600股，占总股本0.0008%交易信息汇总：变动期间公司股价上涨14.61%股本股东变化：7月15日收盘价为40.4元股本股东变化高管增减持2026年7月15日，公司董事、核心技术人员王津津减持公司股份600.0股，占公司总股本0.0008%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651419454","title":"南模生物：7月15日董事王津津减持股份合计600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651419454","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651419454?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:01","pubTimestamp":1784203281,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月16日市场公开信息、上市公司公告及交易所披露数据整理，南模生物最新董监高及相关人员股份变动情况：2026年7月15日公司董事,核心技术人员王津津共减持公司股份600.0股，占公司总股本为0.0008%。变动期间公司股价上涨14.61%，7月15日当日收盘报40.4元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600035934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651416680","title":"股市必读：南模生物（688265）新发布《关于2025年年度报告的信息披露监管问询函的回复公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2651416680","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651416680?lang=zh_cn&edition=full","pubTime":"2026-07-13 02:00","pubTimestamp":1783879244,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，南模生物报收于36.3元，上涨3.8%，换手率1.72%，成交量1.34万手，成交额4855.55万元。公司公告汇总：南模生物就2025年年度报告收到上交所问询函并完成回复，涉及主营业务、收入确认、客户拓展、在建工程及应收账款坏账计提等事项。交易信息汇总资金流向7月10日主力资金净流出515.79万元，占总成交额0.0%；游资资金净流入94.24万元，占总成交额0.0%；散户资金净流入421.54万元，占总成交额0.0%。年审会计师对相关事项发表了核查意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300001009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650154678","title":"每周股票复盘：南模生物（688265）每股派现0.125元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2650154678","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650154678?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:28","pubTimestamp":1783794490,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，南模生物报收于36.3元，较上周的36.51元下跌0.58%。公司公告汇总上海南方模式生物科技股份有限公司2025年年度权益分派实施公告：每股派发现金红利0.125元（含税），股权登记日为2026年7月10日，除权（息）日为2026年7月13日，现金红利发放日为2026年7月13日。公司拟以实施权益分派股权登记日总股本扣减回购专用账户股份数为基数，向全体股东每10股派发现金红利1.25元（含税），回购股份不参与分配。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978866","title":"南模生物（688265）披露关于2025年年度报告的信息披露监管问询函的回复公告，7月9日股价上涨1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650978866?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:38","pubTimestamp":1783607895,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，南模生物报收于34.97元，较前一交易日上涨1.69%，最新总市值为27.26亿元。该股当日开盘33.7元，最高35.67元，最低33.7元，成交额达3171.22万元，换手率为1.17%。近日，南模生物发布《关于2025年年度报告的信息披露监管问询函的回复公告》。公告显示，公司就2025年年度报告收到上交所问询函，针对主营业务、收入确认、客户情况、产能布局、装修支出及应收账款等问题进行了回复。年审会计师对相关事项发表了核查意见。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649277866","title":"南模生物（688265）披露关于变更公司财务总监、聘任副总经理的公告，7月6日股价上涨4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649277866","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649277866?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:31","pubTimestamp":1783348276,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，南模生物报收于38.1元，较前一交易日上涨4.36%，最新总市值为29.7亿元。该股当日开盘36.51元，最高38.1元，最低36.02元，成交额达6459.26万元，换手率为2.22%。近日，上海南方模式生物科技股份有限公司发布《关于变更公司财务总监、聘任副总经理的公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600037659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127718","title":"每周股票复盘：南模生物（688265）董事拟减持不超0.0032%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641127718?lang=zh_cn&edition=full","pubTime":"2026-06-07 03:08","pubTimestamp":1780772893,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，南模生物报收于33.32元，较上周的35.23元下跌5.42%。本周关注点公司公告汇总：职工代表董事王津津拟减持不超2,500股，占公司总股本0.0032%公司公告汇总职工代表董事王津津女士直接持有公司股份10,000股，占公司总股本0.0128%，来源于股权激励。因个人资金需要，王津津计划通过集中竞价交易方式减持不超过2,500股，即不超过公司总股本的0.0032%，减持期间为2026年6月25日至2026年9月24日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700001039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640297260","title":"破发股南模生物某技术拟减持 2021上市即巅峰募16.5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2640297260","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640297260?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:14","pubTimestamp":1780474451,"startTime":"0","endTime":"0","summary":"中国经济网北京6月3日讯 南模生物 昨晚披露董事减持股份计划公告称，截至公告披露日，公司职工代表董事王津津直接持有公司股份10,000股，占公司总股本比例为0.0128%，来源于2025年限制性股票激励计划取得的股份，为无限售条件流通股。 因个人资金需要，王津津计划通过集中竞价交易方式减持其所持有的公司股份不超过2,500股，即不超过公司总股本的0.0032%。 南模生物首次公开发行股票的发行费用总额为1.81亿元，其中，保荐及承销费用1.58亿元。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202606/03/20260603849281.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202606/03/20260603849281.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260603/32268788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","688265","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640941350","title":"南模生物（688265）披露董事减持股份计划公告，6月2日股价下跌2.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640941350","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640941350?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:48","pubTimestamp":1780411697,"startTime":"0","endTime":"0","summary":"近日，南模生物披露《董事减持股份计划公告》。公告显示，截至公告披露日，公司职工代表董事王津津女士直接持有公司股份10,000股，占公司总股本0.0128%，来源于股权激励。因个人资金需要，王津津计划通过集中竞价交易方式减持不超过2,500股，即不超过公司总股本的0.0032%，减持期间为2026年6月25日至2026年9月24日。王津津此前已作出持股及减持承诺，本次减持计划与其一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200047603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639360231","title":"每周股票复盘：南模生物（688265）完成32.672万股限制性股票归属","url":"https://stock-news.laohu8.com/highlight/detail?id=2639360231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639360231?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:48","pubTimestamp":1780174092,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，南模生物报收于35.23元，较上周的38.66元下跌8.87%。南模生物当前最新总市值27.47亿元，在医疗服务板块市值排名46/51，在两市A股市值排名4653/5207。本次归属限制性股票数量为326,720股，来源为公司自二级市场回购的A股普通股股票，归属对象为75名激励对象，包括董事、高级管理人员及核心技术骨干。因1名激励对象自愿放弃2.00万股且2名激励对象未完成出资，实际首批归属数量由35.9320万股调整为32.6720万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638453135","title":"南模生物（688265）披露2025年限制性股票激励计划首次授予部分第一个归属期第一批归属结果公告，5月26日股价下跌2.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638453135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638453135?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:55","pubTimestamp":1779807315,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，南模生物报收于37.15元，较前一交易日下跌2.49%，最新总市值为28.96亿元。公告显示，公司已完成2025年限制性股票激励计划首次授予部分第一个归属期第一批的股份归属登记。其中，孙瑞林、王津津分别归属2.00万股和1.00万股，其余73人合计归属29.672万股。因1名激励对象自愿放弃2.00万股且2名激励对象未完成出资，实际首批归属数量由35.9320万股调整为32.6720万股。公司已收到股票认购款共计4,204,886.40元，股份登记已于2026年5月26日完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688265"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637376440","title":"每周股票复盘：南模生物（688265）2025年年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2637376440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637376440?lang=zh_cn&edition=full","pubTime":"2026-05-24 05:12","pubTimestamp":1779570734,"startTime":"0","endTime":"0","summary":"公司公告汇总上海南方模式生物科技股份有限公司于2026年5月18日召开2025年年度股东会，会议审议通过2025年度董事会工作报告、2025年年度报告及其摘要、2025年度利润分配方案、续聘会计师事务所、董事及高管薪酬相关议案，以及对外出租部分闲置场地的议案。北京市通商律师事务所就上海南方模式生物科技股份有限公司2025年年度股东会的召集、召开程序、召集人和出席会议人员资格、表决程序及表决结果出具法律意见书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688265","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786560931563,"stockEarnings":[{"period":"1week","weight":0.215},{"period":"1month","weight":0.2505},{"period":"3month","weight":0.1054},{"period":"6month","weight":-0.046},{"period":"1year","weight":-0.1108},{"period":"ytd","weight":0.0687}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海南方模式生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6840人(较上一季度增加2.58%)","perCapita":"11398股","listingDate":"2021-12-28","address":"上海市浦东新区琥珀路63弄1号6层","registeredCapital":"7796万元","survey":" 上海南方模式生物科技股份有限公司的主营业务是基因修饰动物模型的研发、生产、销售和技术服务业务。公司的主要产品是定制化模型、标准化模型、模型繁育、药物评价及表型分析、饲养服务。","listedPrice":84.62},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南模生物(688265)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南模生物(688265)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南模生物,688265,南模生物股票,南模生物股票老虎,南模生物股票老虎国际,南模生物行情,南模生物股票行情,南模生物股价,南模生物股市,南模生物股票价格,南模生物股票交易,南模生物股票购买,南模生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南模生物(688265)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南模生物(688265)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}